Dr Caroline R Spencer, OD | |
1303 Suite 108 Us Hwy. 127 S., Frankfort, KY 40601-4424 | |
(502) 875-3050 | |
(502) 226-4261 |
Full Name | Dr Caroline R Spencer |
---|---|
Gender | Female |
Speciality | Optometry |
Experience | 5 Years |
Location | 1303 Suite 108 Us Hwy. 127 S., Frankfort, Kentucky |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1104486489 | NPI | - | NPPES |
2154DT | Other | KY | KENTUCKY LICENSE |
18004159A | Other | IN | INDIANA LICENSE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
152W00000X | Optometrist | 18004159A (Indiana) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Gaddie Eye Centers Llc | 6103898895 | 9 |
News Archive
Six common species of bacteria were found at significantly higher levels in the saliva of patients with oral squamous cell carcinoma (OSCC) than in the saliva of healthy individuals.
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the investigational anti-Xa intravenous anticoagulant otamixaban reduced by 27 to 42 percent the odds of the composite primary endpoint of death, myocardial infarction, urgent revascularization or rescue GPIIb/IIIa use in 4 out of the 5 otamixaban tested doses, versus standard UFH/eptifibatide combination in [non-ST] ACS patients suitable for invasive strategy.
SQI Diagnostics Inc., a medical systems company focused on evolving laboratory-based biomarker testing, today announced that Gamma-Dynacare Medical Laboratories, one of Canada's largest providers of laboratory services, has agreed to put into operation SQI's SQiDworks(TM) platform, and to purchase SQI's multiplexed IgXplex(TM) Rheumatoid Arthritis consumables to meet its commercial needs.
Four major health insurers announced plans yesterday to pool their health care claims data into a single database to enable researchers to mine for information about trends in costs, utilization and intensity of care.
Biotage, a leading supplier of tools and technology for medicinal and analytical chemistry, announced an agreement to extend the research collaboration with Professor Knud J. Jensen at the Faculty of Life Sciences, University of Copenhagen, to develop new applications on the Biotage Syro Wave in the field of synthetic peptide and protein chemistry. The collaboration builds on Professor Jensen's previous research in developing novel chemistries for and applications of solid-phase peptide synthesis.
› Verified 4 days ago
Provider Name | Gaddie Eye Centers Llc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1790759884 PECOS PAC ID: 6103898895 Enrollment ID: O20040812000346 |
News Archive
Six common species of bacteria were found at significantly higher levels in the saliva of patients with oral squamous cell carcinoma (OSCC) than in the saliva of healthy individuals.
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the investigational anti-Xa intravenous anticoagulant otamixaban reduced by 27 to 42 percent the odds of the composite primary endpoint of death, myocardial infarction, urgent revascularization or rescue GPIIb/IIIa use in 4 out of the 5 otamixaban tested doses, versus standard UFH/eptifibatide combination in [non-ST] ACS patients suitable for invasive strategy.
SQI Diagnostics Inc., a medical systems company focused on evolving laboratory-based biomarker testing, today announced that Gamma-Dynacare Medical Laboratories, one of Canada's largest providers of laboratory services, has agreed to put into operation SQI's SQiDworks(TM) platform, and to purchase SQI's multiplexed IgXplex(TM) Rheumatoid Arthritis consumables to meet its commercial needs.
Four major health insurers announced plans yesterday to pool their health care claims data into a single database to enable researchers to mine for information about trends in costs, utilization and intensity of care.
Biotage, a leading supplier of tools and technology for medicinal and analytical chemistry, announced an agreement to extend the research collaboration with Professor Knud J. Jensen at the Faculty of Life Sciences, University of Copenhagen, to develop new applications on the Biotage Syro Wave in the field of synthetic peptide and protein chemistry. The collaboration builds on Professor Jensen's previous research in developing novel chemistries for and applications of solid-phase peptide synthesis.
› Verified 4 days ago
Provider Name | Louisville Optometric Centers Iii, Psc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1134111271 PECOS PAC ID: 8729041926 Enrollment ID: O20041109000487 |
News Archive
Six common species of bacteria were found at significantly higher levels in the saliva of patients with oral squamous cell carcinoma (OSCC) than in the saliva of healthy individuals.
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the investigational anti-Xa intravenous anticoagulant otamixaban reduced by 27 to 42 percent the odds of the composite primary endpoint of death, myocardial infarction, urgent revascularization or rescue GPIIb/IIIa use in 4 out of the 5 otamixaban tested doses, versus standard UFH/eptifibatide combination in [non-ST] ACS patients suitable for invasive strategy.
SQI Diagnostics Inc., a medical systems company focused on evolving laboratory-based biomarker testing, today announced that Gamma-Dynacare Medical Laboratories, one of Canada's largest providers of laboratory services, has agreed to put into operation SQI's SQiDworks(TM) platform, and to purchase SQI's multiplexed IgXplex(TM) Rheumatoid Arthritis consumables to meet its commercial needs.
Four major health insurers announced plans yesterday to pool their health care claims data into a single database to enable researchers to mine for information about trends in costs, utilization and intensity of care.
Biotage, a leading supplier of tools and technology for medicinal and analytical chemistry, announced an agreement to extend the research collaboration with Professor Knud J. Jensen at the Faculty of Life Sciences, University of Copenhagen, to develop new applications on the Biotage Syro Wave in the field of synthetic peptide and protein chemistry. The collaboration builds on Professor Jensen's previous research in developing novel chemistries for and applications of solid-phase peptide synthesis.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Caroline R Spencer, OD 4000 Poplar Level Rd, Louisville, KY 40213-1524 Ph: (502) 813-8928 | Dr Caroline R Spencer, OD 1303 Suite 108 Us Hwy. 127 S., Frankfort, KY 40601-4424 Ph: (502) 875-3050 |
News Archive
Six common species of bacteria were found at significantly higher levels in the saliva of patients with oral squamous cell carcinoma (OSCC) than in the saliva of healthy individuals.
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the investigational anti-Xa intravenous anticoagulant otamixaban reduced by 27 to 42 percent the odds of the composite primary endpoint of death, myocardial infarction, urgent revascularization or rescue GPIIb/IIIa use in 4 out of the 5 otamixaban tested doses, versus standard UFH/eptifibatide combination in [non-ST] ACS patients suitable for invasive strategy.
SQI Diagnostics Inc., a medical systems company focused on evolving laboratory-based biomarker testing, today announced that Gamma-Dynacare Medical Laboratories, one of Canada's largest providers of laboratory services, has agreed to put into operation SQI's SQiDworks(TM) platform, and to purchase SQI's multiplexed IgXplex(TM) Rheumatoid Arthritis consumables to meet its commercial needs.
Four major health insurers announced plans yesterday to pool their health care claims data into a single database to enable researchers to mine for information about trends in costs, utilization and intensity of care.
Biotage, a leading supplier of tools and technology for medicinal and analytical chemistry, announced an agreement to extend the research collaboration with Professor Knud J. Jensen at the Faculty of Life Sciences, University of Copenhagen, to develop new applications on the Biotage Syro Wave in the field of synthetic peptide and protein chemistry. The collaboration builds on Professor Jensen's previous research in developing novel chemistries for and applications of solid-phase peptide synthesis.
› Verified 4 days ago
Dr. Brian Leigh Keplinger, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 15 Grandview Dr, Ste D, Frankfort, KY 40601 Phone: 502-695-1771 Fax: 502-695-1448 | |
Lance Long, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1303 Suite 108 Us 127 South, Frankfort, KY 40601 Phone: 502-875-3050 Fax: 502-226-4261 | |
Anthony Joseph Bisotti, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 100 Diagnostic Dr, Frankfort, KY 40601 Phone: 502-875-9860 | |
Jessica Crum, OD Optometrist Medicare: Medicare Enrolled Practice Location: 315 Leonardwood Rd, Frankfort, KY 40601 Phone: 502-223-2314 Fax: 502-451-8663 | |
Eye Care For Kentucky Optometrist Medicare: Not Enrolled in Medicare Practice Location: 102 Diagnostic Dr, Frankfort, KY 40601 Phone: 502-223-8258 Fax: 502-875-9481 | |
Dr. Paula Frances Hernandez Hoover, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 301 Leonardwood Rd, Frankfort, KY 40601 Phone: 502-223-8555 |